Business Wire

Orchid Labs Introduces the Orchid™ Protocol and Tokens to Create an Internet Free from Surveillance and Censorship

Jaa

Orchid Labs Inc. has unveiled itself publicly today, along with the launch of the private alpha version of its Orchid Network accompanied by a whitepaper. The Orchid protocol is an open-source network intended to end internet surveillance and censorship, while protecting users’ personal data from being harvested by ISPs or other entities. Early in 2018, the blockchain-based Orchid network beta will launch to the public, enabling people across the world to freely communicate, collaborate, and access information.

According to Freedom House, two-thirds of all internet users live in countries where censorship and surveillance limit their ability to access information and communicate. For these individuals, a click or a share can mean imprisonment, or worse. And wherever you live, ISPs and VPNs are profiting from the sale of users’ most sensitive and private information.

Like many other dedicated people around the world, the founders of Orchid Labs are fighting to end these practices and bring an open and liberated internet to everyone in the world. The Orchid protocol is their contribution to this movement for internet freedom—meaning internet that can’t be controlled by corporations or governments and is open and accessible to all. The co-founders share more of their vision and the mission behind the open source technology project that contributes to this cause in the statement they published today.

Founding Team and Leadership

The Orchid founders, an established group of technologists, entrepreneurs, and blockchain experts, have been working in stealth since early 2017 to bring the technology to life. Collectively, the team has extensive expertise in security, networking, blockchain, and open-source software.

  • Stephen Bell: Steve started companies in Europe, the U.S., and China before founding Trilogy VC China, where he spent 10 years backing Chinese seed stage startups.
  • Brian J. Fox: Brian is an entrepreneur and open-source advocate, the first employee of the Free Software Foundation, and the author of the GNU Bash shell.
  • Jay Freeman: Jay is a software engineer and the developer of the Cydia software distribution platform used on millions of jailbroken iOS devices.
  • Gustav Simonsson: Gustav is an engineer and developer who helped launch Ethereum in 2015, working with core protocols, clients, and security auditing.
  • Dr. Steven Waterhouse: Steven is an experienced investor and entrepreneur, having co-founded RPX Corp, led cryptocurrency projects at Fortress and Pantera Capital, and the Honeycomb product at Sun Microsystems.

An Internet with Encrypted, Decentralized Architecture, Incentivized on the Blockchain

Orchid is building a new, surveillance-free layer on top of the internet. It’s fully decentralized, meaning that rather than traffic being routed through central authorities—like a user’s ISP or VPN—it's instead routed randomly through a network of nodes as bandwidth contributors sign up to share their surplus bandwidth. Users that want to access surveillance-free internet pay the bandwidth contributors in Orchid tokens in a free-market ecosystem. Orchid’s technology also ensures that central authorities can’t monitor traffic or payments, so it’s fully anonymous, for both the bandwidth consumer and the bandwidth contributor.

Advisors and Investors

To help provide counsel, Orchid Labs has enlisted a team of advisors with experience in cryptography and mission-driven projects. Orchid’s advisors include Gavin Wood, Founder & CTO at Parity Technologies; Dr. Dan Boneh, Professor and head of Cryptography at Stanford University’s Computer Science Department; and Alexander Lloyd, human rights advocate and Managing Director of Accelerator Ventures.

To support Orchid Labs and its mission, Orchid has raised a $4.7M seed SAFT (Simple Agreement for Future Tokens) from investors including Sequoia, Andreessen Horowitz, DFJ, PolyChain Capital, Metastable, Blockchain Capital, Crunchfund, Struck Capital, Compound VC, European Investor Richard Muirhead, and several other funds and angel investors.

To learn more about Orchid Labs, read their whitepaper, or sign up for more information, visit orchidprotocol.com.

About Orchid Labs Inc.

Orchid Labs Inc. is an open-source project committed to ending surveillance and censorship on the internet. The Orchid protocol uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Stephen Bell, Brian J. Fox, Gustav Simonsson, Dr. Steven Waterhouse, and Jay Freeman. Orchid Labs is headquartered in San Francisco, California.

Contact information

CMO for Orchid Labs Inc.
Louise Callagy, 415-699-2963
press@orchidprotocol.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 12:11Tiedote

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 19:20Tiedote

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 15:31Tiedote

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

Double Win for Vocalink at the 2017 Payments Awards17.11.2017 12:35Tiedote

Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim

Envion AG: Start-up from the Heart of Berlin Has Pioneered Decentralized Mobile Mining by Combining Blockchain with Regenerative Energy17.11.2017 12:00Tiedote

Envion AG has created a technology for the first truly mobile data-center that uses low-priced local energy to mine a broad spectrum of cryptocurrencies (Bitcoin, Ethereum, etc.). By harvesting locally available clean energy right at the source, envion can operate at lower costs than competitors and at the same time reduces the CO2 footprint of the blockchain industry. Envion aims at decentralizing the highly-concentrated mining market (China holds 80% in Bitcoin mining) and at bringing control of the market back to the users. That’s why envion gives 100% of its mining profits back to its community. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171117005011/en/ Envion - World's Most Profitable Standard of Self-Expanding Crypto Infrastructure (Photo: Business Wire) Current challenges in the energy

Chugai's HEMLIBRA® Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors17.11.2017 02:30Tiedote

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the U.S. Food and Drug Administration (FDA) has approved the bispecific antibody emicizumab (US product name: HEMLIBRA®) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. This represents the first regulatory approval for HEMLIBRA® around the world. The US Biologics License Application (BLA) was submitted by Genentech, a member of Roche Group. “We are pleased that HEMLIBRA, a biopharmaceutical created by Chugai scientists based on their exceptional idea, has received its first regulatory approval,” said Chugai’s President & COO, Tatsuro Kosaka. “HEMLIBRA is a first in class biopharmaceutical which is an advancement on the current limited treatment options available for pat

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme